Vang Moua
Medical · Fresno, CANPI 1164682100
Payments from drug & device makers
Across 120 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$488
- Amgen$222
- Mannkind Corporation$176
- AstraZeneca$174
- AbbVie$159
- Biohaven Pharmaceutical Holding Company Ltd.$135
- plus $972 from 22 others
What the payments were for
- Food & beverage$2,17994%
- Education$1476%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $488 |
| Amgen | 18 | $222 |
| Mannkind Corporation | 7 | $176 |
| AstraZeneca | 9 | $174 |
| AbbVie | 7 | $159 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $135 |
| Bayer | 5 | $129 |
| Lilly USA, LLC | 7 | $129 |
| Novo Nordisk | 5 | $115 |
| Boehringer Ingelheim | 4 | $66 |
| Exact Sciences | 2 | $66 |
| Biohaven Pharmaceuticals, Inc. | 3 | $55 |
| GSK | 3 | $51 |
| Phadia US Inc. | 3 | $49 |
| Dexcom, Inc. | 2 | $39 |
| Merck | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Abbott | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Gilead | 1 | $13 |
| Dynavax Technologies Corporation | 1 | $12 |
How this compares
$2,326 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 41 | $68,254 |
| JardianceEmpagliflozin | 50 | $52,798 |
| EliquisApixaban | 32 | $20,100 |
| OzempicSemaglutide | 14 | $11,400 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 34 | $9,526 |
| JanuviaSitagliptin Phosphate | 17 | $8,946 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $7,901 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $6,991 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $5,096 |
| Advair HfaFluticasone Propion/Salmeterol | 16 | $4,992 |
| BreynaBudesonide/Formoterol Fumarate | 36 | $4,376 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,661 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 153 | $3,569 |
| Arnuity ElliptaFluticasone Furoate | 13 | $2,280 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $2,208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $129 | $68,25441 claims |
| Boehringer IngelheimJardiance | $66 | $52,79850 claims |
| GSKBreo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta | $51 | $20,83461 claims |
| PfizerEliquis | $488 | $20,10032 claims |
| Novo NordiskOzempic | $115 | $11,40014 claims |
| MerckJanuvia | $36 | $8,94617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 medical providers in California.
Other medical in Fresno
- David PenaFresno$18K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.